PI3K/mTOR inhibition promotes the regression of experimental vascular malformations driven by PIK3CA-activating mutations

Laura di Blasio(Candiolo Cancer Institute), Luca Primo(Candiolo Cancer Institute)
Cell Death and Disease
January 19, 2018
Cited by 112


Related Papers